clinical trial · NCT07439250
A Study of Olomorasib (LY3537982) in Healthy Participants
Eli Lilly and Company·phase1·recruiting·n = 15
HealthyOlomorasibFluconazole
brief summary
The main purpose of this study in healthy participants is to determine the effect of fluconazole on the amount of study drug that gets into the bloodstream and how long it takes the body to get rid of it. For each participant, the study will last up to approximately 7 weeks and will require 12 overnight stays in the research center.
started
Mar 2, 2026
primary completion
Apr 1, 2026
completion
Apr 1, 2026
last updated
Mar 23, 2026
official title
A Phase 1, Open-Label, Fixed-Sequence Study to Investigate the Effect of Fluconazole on the Pharmacokinetics of Olomorasib (LY3537982) in Healthy Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol